ArticleCancer cell international2022

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner.

Daojia Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.